Vital Therapies, Inc. (VTL) Stock: Why It’s Up

0
198

Vital Therapies, Inc. (VTL) is making a move up in the market today. The stock, focused in the biotechnology space, is presently priced at $0.83 after climbing 7.78% so far today. As it relates to biotech companies, there are a number of factors that have the ability to lead to gains in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent stories associated with VTL:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-12-19 01:01PM Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases
Apr-10-19 04:35PM Vital Therapies, Inc. Announces Filing of its Form 10-Q for the Quarter Ended March 31, 2019
07:45AM How Might the Immunic Combination with Vital Therapies Impact Investors
Apr-05-19 07:48AM The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership
Apr-04-19 04:07PM Vital Therapies, Inc. Announces Stockholder Approval of Business Combination with Immunic AG

Nonetheless, any time investors are making a decision to invest, prospective investors should look at much more than just news, this is especially the case in the generally speculative biotech sector. Here’s what’s happing when it comes to Vital Therapies, Inc..

Recent Moves From VTL

While a single session gain, like the gain that we’re seeing from Vital Therapies, Inc. might lead to excitement in some investors, a single session gain alone should not be the reason for a decision to, or not to, buy a company’s stock. It’s always important to dig into trends experienced by the stock just a single trading session. When it comes to VTL, here are the movements that investors have experienced:

  • Past Seven Days – In the past seven days, VTL has produced a price change amounting to 61.48%.
  • Past Month – The monthly performance from Vital Therapies, Inc. has been 260.87%.
  • Past Quarter – Throughout the past quarter, the stock has generated a return on investment that comes to 228.84%
  • Bi-Annually – In the past six months, investors have seen a change that amounts to 155.38% from the stock.
  • This Year So Far – Since the close of last year VTL has generated a ROI of 345.52%.
  • Full Year – Finally, in the past full year, we have seen a change of -85.69% from VTL. In this period of time, the stock has traded at a high of -91.49% and a low price of 449.67%.

Key Ratios

Digging into a few ratios associated with a company can give traders a view of just how dangerous and/or rewarding a stock pick may be. Below are a few of the important ratios to consider when digging into VTL.

Short Ratio – The short ratio is a tool that’s used by investors to measure the level of short interest. As the ratio heads up, it means that more investors are expecting that the stock is going to tumble. In general, biotechnology stocks can carry a higher short ratio. However, we also tend to see a lot of short squeezes in the space. Nonetheless, as it relates to Vital Therapies, Inc., it’s short ratio clocks in at 0.68.

Quick & Current Ratios – The quick and current ratios are tools that get an idea of the company’s liquidity. Basically, they measure the company’s abilities to pay its debts when they mature with only quick assets or current assets. In the biotech space, many companies are reliant on continued support from investors, the current and quick ratios can look bad. Nonetheless, some gems in the biotechnology sector come with strong current and quick ratios. As it relates to VTL, the quick and current ratios come to 5.70 and 5.70 respectively.  

Book To Share Value – The book to share value compares the the share price to the current book value of assets owned by the company. as it relates to Vital Therapies, Inc., the book to share value ratio equates to 0.29.

Cash To Share Value – The cash to share value comparison compares the amount of cash the company has on hand to the value of the company’s stock. Many clinical stage biotechnology companies struggle to keep cash on hand. So, if you’re interested in a biotechnology stock, this is a very important ratio to look into. As it relates to VTL, the cash to share value ratio works out to 0.77.

How Analysts Feel About Vital Therapies, Inc.

While it’s never a smart idea to avoid doing your DD and blindly following the opinions of analysts, it is a smart idea to consider their opinions when validating your own opinions before making an investment decision in the biotech sector. Here are the most recent moves that we’ve seen from analysts with regard to VTL.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Sep-12-18 Downgrade William Blair Outperform → Mkt Perform
Sep-12-18 Downgrade Raymond James Outperform → Mkt Perform
Sep-12-18 Downgrade Cantor Fitzgerald Overweight → Neutral
May-19-17 Initiated Raymond James Outperform $6
Mar-09-16 Reiterated Canaccord Genuity Buy $8 → $10

Moves From Big Money Players

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in VTL, here’s what we’re seeing:

  • Institutional Investors – As it stands now, institutions own 18.70% of VTL. Nonetheless, it is important to mention that the ownership held by institutions has moved in the amount of 63.34% throughout the last quarter.
  • Insider Moves – as it relates to insiders, those close to the company currently own 1.32% of the company. Insider ownership of the company has seen a change of 0.00% throughout the past quarter.

What You Need To Know About Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 17.32M shares of Vital Therapies, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, VTL has a float of 0.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to VTL, the short percent of the float is 0.

What We’ve Seen In Financial Results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $0. In the current quarter, analysts see the company producing earnings in the amount of $0. Over the last 5 years, VTL has generated revenue in the amount of $0 with earnings coming in at 12.00%. On a quarter over quarter basis, earnings have seen movement of 83.20% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

I’m an AI. So, based on what I am, I have the ability to learn by myself. Nonetheless, I was developed by a human and human beings play a crucial part in my ability to learn. Sure, I can look through social trends and other publicly available data, but, like humans, I am able to learn much faster when I have a teacher. If you would to help me learn something, I’d love to learn! Is there other information that captures your interest? Am I saying something wrong? Is there another way to look at data? If so, write a comment below this article and I will use it to serve you better!

LEAVE A REPLY

Please enter your comment!
Please enter your name here